- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04685551
Improving Survivorship Among Minority Cancer Dyads
22. juli 2022 opdateret af: Charles Drew University of Medicine and Science
Improving Survivorship Outcomes for African American and Latinx Cancer Survivors and Caregiver Dyads Through A Culturally Based Training Program for Underserved Health Professional Students
This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads.
As a result, there will be four major outcomes.
First, as a result of partnership with minority social institutions (e.g.
faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs).
Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students.
Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers.
Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes.
The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.
Studieoversigt
Status
Trukket tilbage
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90059
- Charles R. Drew University of Medicine & Science
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Aim 1 Focus Group for Cancer Survivors and Caregivers:
Inclusion Criteria
- Individuals ages 18 and older
- identify as African American or Latinx
- identify as a cancer survivor and/or caregiver
- speak and/or understand English
Exclusion Criteria
- individuals ages 17 years or younger
- does not identify as African American or Latinx
- unable to speak or understand English
- does not identify as a cancer survivor or caregiver
Aim 1 Focus Group for Oncology Healthcare Providers:
Inclusion Criteria
- Individuals ages 18 and older
- identify as a healthcare provider
- provide care to cancer patients in current provider role
- speak and/or understand English
Exclusion Criteria
- individuals ages 17 years or younger
- unable to speak or understand English
- does not provide care to cancer patients
- does not identify as a healthcare provider
Aim 2:
Inclusion Criteria
- Individuals ages 18 and older
- registered as a CDU student
- speak and/or understand English
- considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care)
Exclusion Criteria
- individuals ages 17 years or younger
- not registered as a CDU student
- unable to speak or understand English
- not considered to be underserved
For Aim 3:
Inclusion Criteria
- cancer survivor with a participating caregiver
- stage III or stage IV cancer diagnosis
- breast, lung, or colorectal cancer diagnosis
- identify as African American or Latinx
- speak and/or understand English
Exclusion Criteria
- individuals ages 17 years or younger
- does not identify as African American or Latinx
- unable to speak or understand English
- does not identify as a cancer survivor
- cancer survivor does not identify a caregiver
- does not have a breast, lung, or colorectal cancer diagnosis
- not diagnosed with a stage III or stage IV cancer diagnosis
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Survivorship Management among African American and Latinx Cancer Dyads
This arm will implement a "one group pre-test and posttest" design to improve health outcomes of African American and Latinx cancer survivors and caregivers in collaboration with health professional students trained as Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs).
|
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Increase in psychosocial well-being using the Quality of Life: Short Form Health Survey and the Center for Epidemiologic Studies Depression Scale
Tidsramme: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% increase in the psychosocial well-being among study participants.
|
3 months
|
Reduction of barriers to symptom management Using the Symptom Distress Scale survey
Tidsramme: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% decrease in the barriers to symptom management among study participants.
|
3 months
|
3. Decrease in unmet needs Using the Barriers to Follow-Up Care Survey and Cancer Survivors Unmet Needs instrument
Tidsramme: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% decrease in the unmet needs among study participants.
|
3 months
|
Reduction in caregiver burden using the Caregiver reaction assessment (CRA) survey
Tidsramme: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% decrease in the caregiver burden among study participants.
|
3 months
|
5. Increase knowledge and utilization of supportive services using the Medical Outcomes Study Social Support Survey
Tidsramme: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% increase in the knowledge and utilization of supportive services among study participants.
|
3 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Sharon Cobb, Charles R. Drew University of Medicine & Science
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
1. juli 2021
Primær færdiggørelse (Forventet)
30. juni 2024
Studieafslutning (Forventet)
31. december 2024
Datoer for studieregistrering
Først indsendt
22. december 2020
Først indsendt, der opfyldte QC-kriterier
22. december 2020
Først opslået (Faktiske)
28. december 2020
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
26. juli 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
22. juli 2022
Sidst verificeret
1. juli 2022
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CancerDyads
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .